Jarrod Longcor
Director de Operaciones en CELLECTAR BIOSCIENCES, INC. .
Fortuna: 164 206 $ al 31/05/2024
Cargos activos de Jarrod Longcor
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Director de Operaciones | 23/02/2022 | - |
| Corporate Officer/Principal | 18/09/2017 | 23/02/2022 |
Historial de carrera de Jarrod Longcor
Antiguos cargos conocidos de Jarrod Longcor.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/07/2014 | 01/07/2016 |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 25/02/2010 | 01/09/2013 |
| MAXCYTE, INC. | Corporate Officer/Principal | 01/03/2006 | - |
Middlebrook Pharmaceuticals, Inc.
 Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Corporate Officer/Principal | - | - |
Formación de Jarrod Longcor.
| Dickinson College | Undergraduate Degree |
| Erivan K. Haub School of Business | Masters Business Admin |
| Boston University School of Medicine | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
| Reino Unido | 2 |
Operativa
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MAXCYTE, INC. | Health Technology |
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Health Technology |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Jarrod Longcor
- Experiencia
